Abstract
This invited commentary discusses the article by Richards et al. describing differences in rates of on-time HPV vaccination and cervical cancer screening in 2018 among enrollees in different insurance plans. The commentary focuses on the larger problem of low vaccination HPV rates and decreasing cervical cancer screening rates seen across all sectors. We outline challenges posed by the COVID-19 pandemic on HPV vaccination and cervical cancer screening, and discuss opportunities to improve cervical cancer prevention.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, pandemic, Screening, cervical cancer, Cervical precancer, HPV, HPV vaccination, 【초록키워드】 vaccination, COVID-19 pandemic, Cancer, Richard, IMPROVE, 【제목키워드】 vaccination, COVID-19 pandemic, Cancer, challenge,
【저자키워드】 COVID-19, SARS-CoV-2, pandemic, Screening, cervical cancer, Cervical precancer, HPV, HPV vaccination, 【초록키워드】 vaccination, COVID-19 pandemic, Cancer, Richard, IMPROVE, 【제목키워드】 vaccination, COVID-19 pandemic, Cancer, challenge,